40
Growth Score in past quarter
pts
Heat Score 40 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
226928
Ichnos Glenmark Innovation develops treatments for haematological malignancies and solid tumors using its BEAT® MultispecificsTM platform.
About the Company
Ichnos Glenmark Innovation focuses on developing treatments for haematological malignancies and solid tumors. The company leverages its proprietary BEAT® MultispecificsTM platform and small molecules to advance its clinical-stage oncology portfolio. Ichnos Glenmark Innovation is an alliance between Ichnos Sciences Inc. and Glenmark Pharmaceuticals
Limited, combining expertise to bring new hope for patients through innovative solutions in biotechnology.